Deborah Ramsdell
Vorstandsvorsitzender bei Valerion Therapeutics LLC
Ursprung des Netzwerks ersten Grades von Deborah Ramsdell
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Orphan Technologies Ltd.
 Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Alopexx Enterprises LLC
 Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA.
5
| Private Company | Biotechnology | 5 |
Phoenicis Therapeutics, Inc.
 Phoenicis Therapeutics, Inc. BiotechnologyHealth Technology Phoenicis Therapeutics, Inc. is a private company that is focused on developing therapies for rare dermatological disorders. The company is based in Hingham, MA. The company's goal is to improve the lives of those who suffer from these conditions. The CEO of the company is Deborah Ramsdell.
4
| Private Company | Biotechnology | 4 |
Valerion Therapeutics LLC
 Valerion Therapeutics LLC Medical SpecialtiesHealth Technology Valerion Therapeutics LLC develops targeted therapies for orphan genetic diseases. The firm utilizes a proprietary antibody-mediated delivery platform to target therapies to specific tissues via a studied transport pathway. It therapies are based on an intracellular delivery technology platform that takes advantage of tissue targeting via an antibody and intracellular delivery dependent on membrane expression of a nucleoside transporter. The company was founded by Timothy S. Harris and Dustin D. Armstrong in 2007 and is headquartered in Concord, MA.
4
| Holding Company | Medical Specialties | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Deborah Ramsdell
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| DYAX CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Cognoptix, Inc.
 Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Cognoptix, Inc. develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease. It offers technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye. The firm also develops combined optical scanning devices and diagnostic agents for clinical, commercial and academic research use. The company was founded by Lee E. Goldstein and Leo T. Chylack Jr in 2001 and is headquartered in Acton, MA. | Hospital/Nursing Management | Director/Board Member | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SHIRE | Pharmaceuticals: Major | General Counsel | |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Provenance Biopharmaceuticals Corp.
 Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Medical Specialties | Corporate Officer/Principal | |
Janus Biotherapeutics, Inc.
 Janus Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Janus Biotherapeutics, Inc. is an autoimmunity therapeutics company, which develops orally available compounds for the treatment of autoimmune diseases. The company was founded by Joseph Baron and Grayson Lipford and is headquartered in Wellesley, MA. | Pharmaceuticals: Major | Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree | |
| Dartmouth College | College/University | Masters Business Admin | |
| Wayne State University (Michigan) | College/University | Undergraduate Degree | |
The Colorado College
 The Colorado College Other Consumer ServicesConsumer Services Colorado College provide a broad liberal arts education to students. The college was founded in May 6, 1874 and it is headquartered in Colorado Springs, CO | College/University | Undergraduate Degree | |
| The University of Texas at Austin | College/University | Doctorate Degree | |
| The University of Chicago | College/University | Doctorate Degree | |
| Yale University | College/University | Corporate Officer/Principal | |
| St. Joseph's University | College/University | Masters Business Admin | |
| University of Illinois | College/University | Undergraduate Degree | |
University of the Pacific
 University of the Pacific Other Consumer ServicesConsumer Services University of the Pacific is a nationally ranked university with a long tradition of dedicated teaching, small class sizes, practical experience and vibrant residential life. The breathtaking main campus in Stockton, California is home to seven schools and colleges, with more than 80 majors and programs of study. Pacific also has the McGeorge School of Law in Sacramento and the Arthur A. Dugoni School of Dentistry in San Francisco. Total university enrollment is nearly 7,000, with 3,757 undergraduates in an average class size of 19 and a student/faculty ratio of 14:1. It is located in Stockton, California. | College/University | Undergraduate Degree | |
The Mount Sinai Hospital
 The Mount Sinai Hospital Hospital/Nursing ManagementHealth Services The Mount Sinai Hospital provides medical and healthcare services. The company was founded in 1952 and is headquartered in New York, NY. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
| Baylor College of Medicine | College/University | Doctorate Degree | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Pritzker School of Medicine | College/University | Doctorate Degree | |
| Columbia College (New York) | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Pittsburgh School of Medicine | College/University | Corporate Officer/Principal | |
| Caregiver Action Network | Director/Board Member | ||
| Biotechpartnering Solutions LLC | Founder | ||
Chromaderm, Inc.
 Chromaderm, Inc. BiotechnologyHealth Technology Chromaderm, Inc. operates as a clinical stage biotech company. It develops topical PKC-beta inhibitor. The company was founded by Barbara A. Gilchrest, Mark de Souza and James W. Fordyce and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
NFlection Therapeutics, Inc.
 NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Biotechnology | Founder | |
Meissa Vaccines, Inc.
 Meissa Vaccines, Inc. BiotechnologyHealth Technology Meissa Vaccines, Inc. operates as a pharmaceutical development company. It focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus. The company was founded by Marty Moore and Roderick Tang in 2014 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer | |
FIBRX Derm, Inc.
 FIBRX Derm, Inc. Pharmaceuticals: MajorHealth Technology FIBRX Derm, Inc. develops anti-scarring therapeutic for patients with Dystrophic Epidermolysis Bullosa. The company was founded by Mark de Souza, James W. Fordyce and Erkki Ruoslahti and is headquartered in Berkeley, CA. | Pharmaceuticals: Major | Founder | |
SeylanMED LLC
 SeylanMED LLC Miscellaneous Commercial ServicesCommercial Services SeylanMED LLC operates as a private biopharmaceutical company that develops a targeted therapy for Seborrheic Keratosis. The company as founded by Victor Neel and Anna Mandinova and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| TRANSCODE THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
SonALAsense, Inc.
 SonALAsense, Inc. BiotechnologyHealth Technology SonALAsense, Inc. provides ALA Sonodynamic Therapy for the treatment of Glioblastoma Multiforme. The company was founded by Stuart Marcus and is headquartered in Berkeley, CA. | Biotechnology | Founder | |
SeylanMED, Inc.
 SeylanMED, Inc. BiotechnologyHealth Technology SeylanMED, Inc. engages in the development of topical akt inhibitor as a treatment for seborrheic keratosis. The company was founded by Victor Neel and Anna Mandinova and is headquartered in Berkeley, CA. | Biotechnology | Chief Executive Officer | |
| Alopexx Vaccines LLC | Chief Executive Officer | ||
| ALOPEXX, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Executive Officer Founder | |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member | |
NF2 Therapeutics, Inc.
 NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
| Ut College of Pharmacy | College/University | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 50 |
| Irland | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 17 |
| Commercial Services | 5 |
| Health Services | 4 |
Operativ
| Director/Board Member | 46 |
| Corporate Officer/Principal | 31 |
| Chief Executive Officer | 18 |
| Chief Tech/Sci/R&D Officer | 15 |
| Founder | 14 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Peter Honig | 20 |
| Daniel R. Vlock | 17 |
| Larry Ellberger | 16 |
| Margaret McGlynn | 14 |
| Christine de los Reyes | 12 |
| Patrick Taylor Horn | 10 |
| Mark de Souza | 9 |
| Neil Kirby | 8 |
| Hal Landy | 7 |
| Alex J. Silver | 7 |
| Gerald B. Pier | 5 |
| Joff Masukawa | 4 |
| Dave Ramsdell | 3 |
| Dustin D. Armstrong | 2 |
| Frank Glavin | 2 |
- Börse
- Insiders
- Deborah Ramsdell
- Unternehmensverbindungen
